|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
10/09/2023 |
$0.04 |
$0.05 |
$0.03 |
$0.03 |
2.26M | 10/10/2023 |
$0.04 |
$0.05 |
$0.03 |
$0.03 |
2.39M | 10/11/2023 |
$0.03 |
$0.04 |
$0.03 |
$0.04 |
2.44M | 10/12/2023 |
$0.04 |
$0.04 |
$0.04 |
$0.04 |
1.21M | 10/13/2023 |
$0.04 |
$0.04 |
$0.03 |
$0.04 |
752.40K |
|
Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform. | |
|
Navidea Biopharmaceuticals (NAVB) has the following price history information. Looking back at NAVB historical stock prices for the last five trading days, on October 09, 2023, NAVB opened at $0.04, traded as high as $0.05 and as low as $0.03, and closed at $0.03. Trading volume was a total of 2.26M shares. On October 10, 2023, NAVB opened at $0.04, traded as high as $0.05 and as low as $0.03, and closed at $0.03. Trading volume was a total of 2.39M shares. On October 11, 2023, NAVB opened at $0.03, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 2.44M shares. On October 12, 2023, NAVB opened at $0.04, traded as high as $0.04 and as low as $0.04, and closed at $0.04. Trading volume was a total of 1.21M shares. On October 13, 2023, NAVB opened at $0.04, traded as high as $0.04 and as low as $0.03, and closed at $0.04. Trading volume was a total of 752.40K shares.
NAVB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Navidea Biopharmaceuticals shares, starting with a $10,000 purchase of NAVB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
10/13/2023 |
|
Start price/share: |
$39.20 |
|
End price/share: |
$0.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.90% |
|
Average Annual Total Return: |
-51.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10.21 |
|
Years: |
9.54 |
|
|
|
Date |
Close |
10/09/2023 | $0.03 | 10/10/2023 | $0.03 | 10/11/2023 | $0.04 | 10/12/2023 | $0.04 | 10/13/2023 | $0.04 |
|
|